Weekend of Cancer Data at AACR Ahead of ASCO (ALTH, AMGN, ARIA, ARRY, AZN, BIIB, CELG, CRIS, IMMU, IMGN, INFI, MEDX, MNTA, ONCY, PFE, PCYC, SUPG, TELK, THLD)

This weekend will be a potentially important oncology and cancer news weekend for drug and biotech stocks.  The American Association for Cancer Research Meeting will actually have a 100th annual meeting, and some traders and investors may be using this as a preview for what lies ahead at the American Society of Clinical Oncology (ASCO) annual meeting in a month.  The following companies which are presenting data:

• Allos Therapeutics, Inc. (NASDAQ: ALTH)
• Amgen (NASDAQ: AMGN)
• ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA)
• Array BioPharma, Inc. (NASDAQ: ARRY)
• AstraZeneca’s (NYSE: AZN) Medimmune unit
• Biogen Idec Inc. (NASDAQ: BIIB)
• Celgene Corporation (NASDAQ: CELG)
• Curis, Inc. (NASDAQ: CRIS)
• Immunomedics, Inc. (Nasdaq: IMMU)
• ImmunoGen, Inc. (Nasdaq: IMGN)
• Infinity Pharmaceuticals, Inc. (NASDAQ: INFI)
• Medarex, Inc. (Nasdaq: MEDX)
• Momenta Pharmaceuticals, Inc. (Nasdaq: MNTA)
• Oncolytics Biotech, Inc. (NASDAQ: ONCY)
• Pfizer (NYSE: PFE)
• Pharmacyclics, Inc. (NASDAQ: PCYC)
• SuperGen Inc. (NASDAQ:SUPG)
• Telik, Inc. (Nasdaq: TELK)
• Threshold Pharmaceuticals, Inc. (Nasdaq: THLD)

You can see a full summary of the data being presented at BioHealthInvestor.com site.  There will be others presenting data this weekend, and these were from the press releases of the meeting ahead of time.

JON C. OGG